Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis
Work
Year: 2023
Type: article
Abstract: Background Given rapid innovation in advanced therapies for moderately to severely active ulcerative colitis (UC), we investigated their comparative efficacy and safety during induction and maintenan... more
Source: Crohn s & Colitis 360
Institutions University of Calgary, Cedars-Sinai Medical Center, KU Leuven, IRCCS Ospedale San Raffaele, University of Michigan–Ann Arbor +2 more
Cites: 24
Cited by: 37
Related to: 10
FWCI: 13.89
Citation percentile (by year/subfield): 99.99
Topic: Inflammatory Bowel Disease
Subfield: Genetics
Domain: Life Sciences
Sustainable Development Goal Industry, innovation and infrastructure
Open Access status: gold
APC paid (est): $2,975
Funder AbbVie